EDITOR’S NOTE – This is the first in a two-part series on industry reaction to the U.S. House of Representatives passage of the H.R. 2 bill.
The U.S. Senate left for spring break two weeks ago, thereby leaving the $214 billion Medicare Bill, H.R. 2, and the Medicare Access and CHIP Reauthorization Act on the table. H.R. 2 contains no language to delay the implementation of ICD-10, which is mandated to be adopted by Oct. 1, 2015.